Literature DB >> 1336528

The haemodynamics of obesity: a theoretical analysis.

E Ferrannini1.   

Abstract

BACKGROUND: Obesity and hypertension are frequently associated with one another, and changes in body weight are usually accompanied by consensual changes in blood pressure.
OBJECTIVE: To examine formally the haemodynamic conditions required for a weight gain to cause a rise in blood pressure in the resting state.
METHODS: The relevant equations were developed, and then used in a simulation to predict blood pressure and peripheral vascular resistance in response to changes in body weight. The model was tested on data taken from published reports. Furthermore, the impact of the composition of the excess weight, i.e. fat versus muscle tissue, on the haemodynamics of obesity was incorporated into the simulation by using a range of tissue-specific blood flow rates taken from published reports.
RESULTS: The key determinant of weight-induced increases in blood pressure is a disproportional increase in cardiac output, which is not fully accounted for by the haemodynamic contribution of new tissues. An increase in muscle tissue relative to fat in newly gained weight is a further factor in the blood pressure increase arising from any given level of excess weight.
CONCLUSIONS: The disproportional increase in cardiac output in obesity is best attributed to stimulation of cardiac dynamics by the adrenergic nervous system. The low resistance of adipose tissue relative to muscle may be the physiologic basis for the dominance of fat-free mass in multiple regression analyses of blood pressure determinants in the population; it further suggests that in the obese hypertensive, fat tissue may provide protection against cardiovascular disease by limiting increases in total peripheral resistance.

Entities:  

Mesh:

Year:  1992        PMID: 1336528     DOI: 10.1097/00004872-199211000-00015

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

Review 1.  Microvascular responsiveness in obesity: implications for therapeutic intervention.

Authors:  Zsolt Bagi; Attila Feher; James Cassuto
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

2.  Obesity and Cardiovascular Diseases in a High-Risk Population: Evidence-Based Approach to CHD Risk Reduction.

Authors:  John Kwagyan; Tamrat M Retta; Muluemebet Ketete; Cristina N Bettencourt; Abid R Maqbool; Shichen Xu; Otelio S Randall
Journal:  Ethn Dis       Date:  2015       Impact factor: 1.847

3.  Hypertension and combinations of cardiovascular risk factors. An epidemiologic case-control study in an adult population in Guadeloupe (FWI).

Authors:  L Foucan; J Bangou-Brédent; D K Ekouévi; J Deloumeaux; J E Roset; P Kangambega
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 4.  The pathogenesis of hypertension in obese subjects.

Authors:  P Weidmann; M de Courten; L Boehlen; S Shaw
Journal:  Drugs       Date:  1993       Impact factor: 9.546

5.  The prevalence of metabolic syndrome and its association with body fat distribution in middle-aged individuals from Indonesia and the Netherlands: a cross-sectional analysis of two population-based studies.

Authors:  Fathimah S Sigit; Dicky L Tahapary; Stella Trompet; Erliyani Sartono; Ko Willems van Dijk; Frits R Rosendaal; Renée de Mutsert
Journal:  Diabetol Metab Syndr       Date:  2020-01-07       Impact factor: 3.320

6.  Effect of diet and exercise on pulse pressure and cardiac function in morbid obesity: analysis of 24-hour ambulatory blood pressure.

Authors:  Otelio S Randall; John Kwagyan; Zhenqui Huang; Shichen Xu; Muluemebet Ketete; Abid R Maqbool
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-08       Impact factor: 3.738

7.  Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids.

Authors:  Yan Q Chen; Thomas G Pottanat; Robert W Siegel; Mariam Ehsani; Yue-Wei Qian; Eugene Y Zhen; Ajit Regmi; William C Roell; Haihong Guo; M Jane Luo; Ruth E Gimeno; Ferdinand Van't Hooft; Robert J Konrad
Journal:  J Lipid Res       Date:  2020-06-02       Impact factor: 5.922

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.